Active Ingredient History

  • Now
Methoxy polyethylene glycol-epoetin beta, sold under the brand name Mircera, is a long-acting erythropoietin receptor activator (CERA) used for the treatment of anaemia associated with chronic kidney disease. It is the first approved, chemically modified erythropoiesis-stimulating agent (ESA).   Wikipedia

  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: No
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)


$115.9306 - $1044.5539
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

cera | cera (erythropoietin receptor activator) | continuous erythropoietin receptor activator | epo beta | epoetin beta | epoetin-beta | epoetin beta pegol | epoetin beta rdna | epoietin beta | methoxy polyethylene glycol epoetin beta | methoxy polyethylene glycol-epoetin beta | methoxy polyethylene glycol-epoetin-beta | mircera | pegylated epoetin beta | pegzerepoetin alfa | r744 | ro0503821


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue